Search

Displaying 1391 - 1400 of 1478

Omeros Corporation is sponsoring the ARTEMIS-IGAN clinical trial, a randomized, double-blind, placebo-controlled, Phase 3 study of the safety and efficacy of narsoplimab in patients with immunoglobulin A (IgA) nephropathy.

 

RENALINK: A PUBLICATION OF THE NKF Council of NEPHROLOGY NURSES & TECHNICIANS Council of NEPHROLOGY SOCIAL WORKERS Council on RENAL NUTRITION • CNNT Editor: Jennifer Lunt, CHT CNSW Editor: Jeff Harder, LICSW, NSW-C, FNKF CRN Editor: Elizabeth Sussman-Dabach, PHD, RD, FCRS • Editorial Manager: Cayla Guzewski...
Newsletter: RenaLink
Newsletter Date: March, 2022

Natural disasters (blizzards, earthquakes, floods, hurricanes, tornadoes, etc.) or electrical power blackouts can disrupt healthcare services, such as dialysis treatment. The aim of the information on this website is to help you prepare for possible emergencies. By knowing what to do and preparing ahead, you can feel secure if an emergency should occur. You may want to print this information along with the emergency meal plan, and keep it in...